Company Performance Metrics
- Richard Simon: Chief Operating Officer
- Tessa Sawyers: Director of Marketing
SIVOTEC Inc. is a bioinformatics company advancing precision medicine through AI-powered genomic tools. The name SIVOTEC stands for “Signatures In Vivo Through Technology”, reflecting the company’s mission to decode complex biological data using advanced computing.
SIVOTEC is the company behind the GENA™ platform, a suite of solutions designed to
accelerate rare disease diagnosis, improve patient outcomes, and make genetic testing more actionable and accessible. The platform includes:
GENA Screen: A clinical decision support tool that helps providers determine whether genetic testing is warranted based on symptoms and chronic disease indicators.
GENA Test: A genomic testing and analysis solution powered by the GENAMap engine, which enables faster, more accurate interpretation of genetic data.
GENA PLM (in development): A Private Language Model for healthcare, developed in partnership with the University of Miami, designed to support clinical decision-making with specialized biomedical intelligence.
By reducing diagnostic turnaround times by over 95% and cutting per-sample costs, SIVOTEC empowers clinicians, labs, and researchers to deliver earlier, more precise care through AI-enhanced genomics.
